EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mature Tertiary Lymphoid Structures in Breast Cancers Are Associated With Antitumor Immunity and Better Prognosis

Shibo Yu, Mirte Dekker, Mieke C Zwager, Lorian Slagter-Menkema, Tineke van der Sluis, Carolina P Schröder, Marcel A T M van Vugt, Bert van der Vegt

Modern Pathology · 2026-06 · 39 (6) · 101004

DOI: 10.1016/j.modpat.2026.101004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2026-06. Verfasst von Shibo Yu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Hauptthemen laut MEDLINE: Tertiary Lymphoid Structures, Breast Neoplasms, Tumor Microenvironment, Lymphocytes, Tumor-Infiltrating. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Scholarship Council, Merck, Rijksuniversiteit Groningen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tertiary lymphoid structures (TLSs) are immune cells accumulated in nonlymphoid tissues, with an inner core of B cells encompassed by T cells. The aim of this study was to evaluate the clinical importance of mature TLSs in breast cancer, including their association with immunotherapy response and their role in modulating the tumor immune microenvironment. We analyzed histopathological data of 726 consecutive primary breast cancers and transcriptomic data of 824 breast cancer samples from the publicly available The Cancer Genome Atlas database to estimate the clinical and immunological values of mature TLSs in breast cancer. Additionally, we utilized pretreatment transcriptomic data of 69 patients with breast cancer from the publicly available I-SPY2 clinical trial to investigate the relation between TLS-related gene signatures and patient responses to immune checkpoint inhibitors. The existence of mature TLSs was identified in ⁓5.6% (41/726) of all patients with breast cancer (hormone receptor-positive human epidermal growth factor receptor-2 negative (HR+HER2-): 0.92%; triple-negative breast cancer (TNBC): 14.96%; and human epidermal growth factor receptor-2 positive (HER2+): 10.98%) and was independently associated with improved recurrence-free survival after adjusting for subtypes, tumor-infiltrating lymphocyte levels, and tumor stage after the multivariable Cox regression analysis in our patient cohort. Notably, the presence of mature TLSs was related to immune cell infiltration in our breast cancer patient cohort. In line with these findings, TLS-related gene signatures analyzed through transcriptomic data reliably reflected the existence of mature TLSs and were related to better clinical responses to immune checkpoint inhibitors in patients with breast cancer. In conclusion, our findings show that mature TLS formation is linked with immune cell infiltration, contributes to a favorable prognosis, and may function as a potential complementary biomarker for immunotherapy response in breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tertiary Lymphoid StructuresBreast NeoplasmsTumor MicroenvironmentLymphocytes, Tumor-InfiltratingHumansFemalePrognosisMiddle AgedBiomarkers, TumorAgedAdultImmune Checkpoint Inhibitors

Stichwörter der Autor:innen

breast cancerimmunotherapyprognostic biomarkerstertiary lymphoid structurestumor microenvironment

Substanzen

Biomarkers, TumorImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Electronic address: m.vugt@umcg.nl.
  • Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Electronic address: b.van.der.vegt@umcg.nl.

Förderung

  • China Scholarship Council
  • Merck
  • Rijksuniversiteit Groningen
  • MSD

Zitieren

APA

Yu, S., Dekker, M., Zwager, M. C., Slagter-Menkema, L., van der Sluis, T., Schröder, C. P., van Vugt, M. A. T. M., & van der Vegt, B. (2026). Mature Tertiary Lymphoid Structures in Breast Cancers Are Associated With Antitumor Immunity and Better Prognosis. Modern Pathology, 39(6), 101004. https://doi.org/10.1016/j.modpat.2026.101004

Vancouver

Yu S, Dekker M, Zwager MC, Slagter-Menkema L, van der Sluis T, Schröder CP, et al. Mature Tertiary Lymphoid Structures in Breast Cancers Are Associated With Antitumor Immunity and Better Prognosis. Modern Pathology. 2026;39(6):101004. doi:10.1016/j.modpat.2026.101004

BibTeX
@article{Yu2026,
  author = {Yu, Shibo and Dekker, Mirte and Zwager, Mieke C and Slagter-Menkema, Lorian and van der Sluis, Tineke and Schröder, Carolina P and van Vugt, Marcel A T M and van der Vegt, Bert},
  title = {Mature Tertiary Lymphoid Structures in Breast Cancers Are Associated With Antitumor Immunity and Better Prognosis},
  journal = {Modern Pathology},
  year = {2026},
  volume = {39},
  number = {6},
  pages = {101004},
  doi = {10.1016/j.modpat.2026.101004}
}
Kostenlos starten →